ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
-1,03%
Bitcoin
62 977,47
6,52%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Seres Therapeutics Inc (MCRB)

  7. Seres Therapeutics Inc (MCRB) Actualités

MCRB Seres Therapeutics Inc

1,15
0,04 (3,60%)
Après les heures de négociation
Dernière mise à jour : 01:28:05
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Seres Therapeutics Inc MCRB NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,04 3,60% 1,15 01:28:05
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,11 1,08 1,19 1,16 1,11
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
09/4/202413:00BWSeres Therapeutics Announces Completion of Patient..
28/3/202412:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
19/3/202412:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
05/3/202416:18EDGAR2Form DEF 14A - Other definitive proxy statements
05/3/202416:13EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/3/202413:05EDGAR2Form 8-K - Current report
05/3/202413:00BWSeres Therapeutics Reports Fourth Quarter and Full Year 2023..
05/3/202412:05IHMARKETNEWSU.S. Futures Dip, Crude Oil Fluctuates
28/2/202413:00BWSeres Therapeutics to Host Fourth Quarter 2023 Financial..
27/2/202413:00BWSeres Therapeutics to Participate in Cowen 44th Annual..
26/2/202413:06EDGAR2Form 8-K - Current report
26/2/202413:00BWSeres Therapeutics Announces the Appointment of Marella..
23/2/202422:05EDGAR2Form PRE 14A - Other preliminary proxy statements
17/2/202403:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202403:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202403:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202403:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202403:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202422:01EDGAR2Form 8-K - Current report
17/1/202413:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
10/1/202413:00EDGAR2Form 8-K - Current report
09/1/202414:10DJNSeres Therapeutics Shares Rise 15% After Getting FDA..
09/1/202413:05EDGAR2Form 8-K - Current report
09/1/202413:00BWSeres Therapeutics Announces VOWST™ Commercial Launch Update..
04/1/202422:00BWSeres Therapeutics to Participate in the 42nd Annual J.P...
02/1/202422:05EDGAR2Form 8-K - Current report
08/12/202301:46BWSeres Therapeutics Announces Presentation of Preliminary..
28/11/202315:18BWSeres Therapeutics to Participate in the Piper Sandler 35th..
28/11/202301:01PRNUSFlagship Pioneering Marks Official Opening of UK Hub with..
21/11/202312:00PRNUSFlagship Pioneering Unveils Quotient Therapeutics to Create..
02/11/202315:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202312:05EDGAR2Form 8-K - Current report
02/11/202312:00BWSeres Therapeutics Reports Third Quarter 2023 Financial..
01/11/202315:30PRNUSFlagship Pioneering Launches Pioneering Intelligence
01/11/202302:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202302:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202302:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202302:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202302:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202302:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202322:30BWSeres Therapeutics to Announce Third Quarter 2023 Results on..
12/10/202313:00BW Seres Therapeutics to Highlight VOWST™ Data at IDWeek
06/10/202313:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
04/10/202313:00EDGAR2Form 8-K - Current report
11/9/202312:30PRNUSFlagship Pioneering Announces Appointment of Amanda Kay as..
08/9/202313:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
07/9/202316:00BWSeres Therapeutics to Participate in the Morgan Stanley 21st..
29/8/202315:00PRNUSInvaio achieves first registration for citrus greening..
16/8/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
08/8/202322:07EDGAR2Form S-3 - Registration statement under Securities Act of..

Dernières Valeurs Consultées

NASDAQ
MCRB
Seres Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés